-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WB59Dx+MTMVCh6a66I3oPVrIhs7ei83LyNP61Isf3M9bbD3ovBIkADGwRIgtjBtN B6fzJFXSxvVjMVa5xSOAeA== 0001017062-02-001386.txt : 20020716 0001017062-02-001386.hdr.sgml : 20020716 20020716081713 ACCESSION NUMBER: 0001017062-02-001386 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020716 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNEX CORP /DE/ CENTRAL INDEX KEY: 0000719529 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 510346580 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-12406 FILM NUMBER: 02703504 BUSINESS ADDRESS: STREET 1: 51 UNIVERSITY ST CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 2065870430 MAIL ADDRESS: STREET 1: 51 UNIVERSITY STREET CITY: SEATLE STATE: WA ZIP: 98101 15-12G 1 d1512g.htm IMMUNEX CORP. - FORM 15 Prepared by R.R. Donnelley Financial -- Immunex Corp. - Form 15
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 15
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
 
Commission File Number          0-12406        
 
Immunex Corporation
(Exact name of registrant as specified in its charter)
 
51 University Street, Seattle, Washington 98101-2936
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
 
Common Stock, par value $0.01 per share
(Title of each class of securities covered by this Form)
 
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
 
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
 
Rule l2g-4(a)(1)(i)   x
   
Rule l2h-3(b)(l)(i)     x
Rule l2g-4(a)(1)(ii)  ¨
   
Rule 12h-3(b)(1)(ii)  ¨
Rule l2g-4(a)(2)(i)   ¨
   
Rule l2h-3(b)(2)(i)    ¨
Rule l2g-4(a)(2)(ii)  ¨
   
Rule l2h-3(b)(2)(ii)   ¨
    
Rule l5d-6                 ¨
 
Approximate number of holders of record as of the certification or notice date: One (1)
 
Pursuant to the requirements of the Securities Exchange Act of 1934, Immunex Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
 
Date: July 15, 2002
      
By:
  
/s/    STEVEN M. ODRE        
               
Steven M. Odre
Vice President and Assistant Secretary
-----END PRIVACY-ENHANCED MESSAGE-----